MARKET

GCVRZ

Sanofi FR
GCVRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
0.3341
0.0258
0.0165
1,088,892,353.18
BRIEF-Sanofi Says Rilzabrutinib Designated Breakthrough Therapy In US
Reuters · 1d ago
Sanofi erhält FDA-Breakthrough-Therapie-Status für Rilzabrutinib zur Behandlung von wAIHA
Reuters · 1d ago
Sanofi’s Rilzabrutinib Wins FDA Breakthrough Therapy Status for Rare Anemia
Reuters · 1d ago
Sanofi’s Rezurock Wins CHMP Backing for EU Approval in Chronic GVHD
Reuters · 3d ago
EMA empfiehlt Zulassung von Sanofis Rezurock zur Behandlung von chronischer GvHD
Reuters · 3d ago
TRUMPRX.GOV WEBSITE IS LAUNCHED, WEBSITE SHOWS
Reuters · 4d ago
WEBSITE SAYS MANY COMMONLY PRESCRIBED BRAND-NAME DRUGS ARE LISTED ON TRUMPRX, SUCH AS FERTILITY AND WEIGHT LOSS DRUGS
Reuters · 4d ago
BUZZ-OneSpaWorld jumps as co poised to join S&P SmallCap index
Reuters · 4d ago
More

Webull offers Sanofi FR stock information, including NASDAQ: GCVRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCVRZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCVRZ stock methods without spending real money on the virtual paper trading platform.